We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies

Bak4.0

Bakuchiol Research

Mostly mechanism / observationalHigh safety

6 peer-reviewed studies

What the evidence says

Mostly mechanism / observational

Most Bakuchiol studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.

Most evidence is from mixed-quality randomised trials published 2014–2025 with a typical study size of 44 participants.

Based on 6 studies · 3 RCTs · 209 total participants

Confidence

Moderate

By outcome

Skin healthRetinol-like reduction in wrinkle appearance with less irritation (cosmetic; rests largely on one 44-person trial) · 8-12 weeks · May support firmness/elasticity appearance via retinol-like collagen signalling (cosmetic, mechanism-led) · 8-12 weeks
Mostly mechanism / observational3 studies
Skin tone & pigmentationModest improvement in hyperpigmentation appearance (cosmetic; evidence is weak/mixed) · 8-12 weeks
Mostly mechanism / observational3 studies
Safety profile
Too few graded studies1 study

Active research area

2 studies in the last 5 years

201420192025

1RCTn=44 · small study2019

Bakuchiol and retinol both significantly decreased wrinkle surface area and hyperpigmentation, with no statistical difference between the compounds.

Dhaliwal S, Rybak I, Ellis SR, Notay M, Trivedi M, Burney W, Vaughn AR, Nguyen M, Reiter P, Bosanac S, Yan H, Foolad N, Sivamani RK. · Br J Dermatol (2019)

Randomized, double-blind, 12-week study: 44 patients applied bakuchiol 0.5% cream twice daily or retinol 0.5% cream daily
Both significantly decreased wrinkle surface area and hyperpigmentation, with no statistically significant difference between the two compounds
Retinol users reported more facial scaling and stinging — supporting bakuchiol as comparable but better tolerated

View source

2Systematic Review2024

Trials lack methodologic rigor, which introduces a high risk of bias in reported outcomes.

Fanning JE, McGee SA, Ibrahim OI. · J Drugs Dermatol (2024)

Systematic review of 15 human clinical trials of topical bakuchiol for aging, acne, and post-inflammatory hyperpigmentation
Twelve of the 15 trials were unblinded, open-label trials without a control group, and ten used a combination therapy containing bakuchiol
Heterogeneity made meta-analysis unfeasible and the trials carry a high risk of bias — the key counter-evidence on this page

View source

3RCTn=111 · medium study2015

Differences were statistically significant (P<0.05) in favor of BGM complex for inflammatory lesions as well as IGA and seborrhea intensity.

Poláková K, Fauger A, Sayag M, Jourdan E. · Clin Cosmet Investig Dermatol (2015)

Randomized controlled trial in 111 acne patients comparing adapalene 0.1% gel plus a bakuchiol/Ginkgo/mannitol (BGM) complex vs adapalene plus vehicle for 2 months
Adding the BGM complex significantly improved inflammatory lesions, IGA, and seborrhea vs vehicle (P<0.05)
Bakuchiol was tested only as part of a combination product, so its independent acne contribution cannot be isolated (a key limit)

View source

4In Vitro2014

We present evidence that bakuchiol, having no structural resemblance to retinoids, can function as a functional analogue of retinol.

Chaudhuri RK, Bojanowski K. · Int J Cosmet Sci (2014)

Comparative gene-expression profiling in a full-thickness skin model showed great similarity between retinol's and bakuchiol's effects on the gene-expression profile
Bakuchiol upregulated type I, III, and IV collagen, mirroring retinol-like activity despite no structural resemblance to retinoids
Conducted by the commercial developer of the bakuchiol ingredient (industry-linked) — foundational mechanism paper

View source

5Open-Labeln=20 · very small study2020

For TCA-induced PIH sites, there was a statistically significant (p < 0.05) degree of improvement with bakuchiol treatment compared to vehicle and control.

Lyons AB, Kohli I, Nahhas AF, Braunberger TL, Mohammad TF, Nicholson CL, Nartker NT, Modi K, Matsui MS, Lim HW, Hamzavi IH. · Arch Dermatol Res (2020)

Prospective, non-randomized vehicle-controlled trial in 20 subjects (phototypes IV-VI) with a history of acne-induced post-inflammatory hyperpigmentation
Twice-daily bakuchiol significantly improved trichloroacetic-acid-induced PIH versus vehicle and control (p<0.05)
On acne-induced PIH, bakuchiol did NOT reach statistical significance (p>0.05) — a key limit on its pigmentation claim

View source

6RCTn=34 · small study2025

Wrinkle area, SEw, F4 significantly reduced by 16.06%, 16.71%, 25.60%, respectively, and Dermatologist assessment significant decrease in facial wrinkles, while R2 significantly increased by 23.04% after 28 days.

Shi X, Wang Y, Zhang H, Zhang T. · Health Sci Rep (2025)

34 sensitive-skin subjects used a twice-daily serum combining supramolecular bakuchiol and Terminalia chebula extract for 28 days
Wrinkle area, depth, and firmness improved and elasticity increased, with improved barrier/sensitivity markers and no adverse events
Bakuchiol was combined with Terminalia chebula, so its independent effect cannot be separated; very short 28-day duration and industry-funded

View source

View in Research Library

Bakuchiol Research

Mostly mechanism / observational

Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing.

Human Clinical Trials Using Topical Bakuchiol Formulations for the Treatment of Skin Disorders: A Systematic Review.

A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial.

Bakuchiol: a retinol-like functional compound revealed by gene expression profiling and clinically proven to have anti-aging effects.

Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.

Prospective, Randomized, Double-Blind Assessment of Supramolecular Bakuchiol and Terminalia Chebula Extract for Facial Photoaging in Chinese Sensitive Skin Population.